This versatility allows for productive creation of personalised medicines, as manufacturers can adapt swiftly to altering treatment method necessities and generate scaled-down quantities without the need of compromising Expense-efficiency.“Now we have potential out there, but do We've the best capacity at the appropriate time for what is needed?